Yssel H, Groux H
INSERM U454, Hôpital Arnaud de Villeneuve, Montpellier, France.
Int Arch Allergy Immunol. 2000 Jan;121(1):10-8. doi: 10.1159/000024292.
Allergic asthma is a complex and heterogeneous disease which is characterized by intermittent reversible airway obstruction, chronic inflammation of the airways, bronchial hyperreactivity and an infiltration of lymphocytes and eosinophils into the airway submucosa. Animal models and clinical studies in humans have indicated an important role for T helper type 2 lymphocytes, producing IL-4, IL-5 and IL-13, in the pathogenesis of this disorder. However, although IL-4 and IL-13 have strong anti-inflammatory properties, the physiologic anti-inflammatory Th2 response does not seem to be operational in allergic asthma. Moreover, the induction of a Th1 response seems to aggravate, rather than ameliorate, its inflammatory character. This article will focus on the involvement of T lymphocyte subpopulations in the pathogenesis of allergic asthma and allergic diseases. In addition, a potential role of the subpopulation(s) of T regulatory cells in the induction and/or maintaince of the disease process will be discussed.
过敏性哮喘是一种复杂的异质性疾病,其特征为间歇性可逆性气道阻塞、气道慢性炎症、支气管高反应性以及淋巴细胞和嗜酸性粒细胞浸润至气道黏膜下层。动物模型和人体临床研究表明,产生白细胞介素-4、白细胞介素-5和白细胞介素-13的2型辅助性T淋巴细胞在该疾病的发病机制中起重要作用。然而,尽管白细胞介素-4和白细胞介素-13具有强大的抗炎特性,但生理性抗炎性Th2反应在过敏性哮喘中似乎并未发挥作用。此外,Th1反应的诱导似乎会加重而非改善其炎症特征。本文将重点关注T淋巴细胞亚群在过敏性哮喘和过敏性疾病发病机制中的作用。此外,还将讨论调节性T细胞亚群在疾病过程诱导和/或维持中的潜在作用。